Skip to content

144Accepted Nov 24, 4:32 PM ET

Werewolf Therapeutics, Inc. 144

UBS Oncology Impact Fund L.P.

Accepted (ET)

4:32 PM

Nov 24, 2025

Filed

Nov 24, 2025

Documents

2

Size

287.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.